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Subsequent to studies describing porphyrin binding to plasma lipoproteins (Jori et al., 1984; Reyftman et al., 1984; Moan et al., 1985) , including the observation that lipoproteins play an important role in the transport of haematoporphyrin (Hp) in the bloodstream (Jori et al., 1984) , it has been suggested that the tumour localising property of the porphyrin photosensitisers used in photodynamic therapy (PDT) is related to such binding, particularly to low density lipoprotein (LDL) (Reyftman et al., 1984; Barel et al., 1986; Kessel, 1986; Kessel et al., 1987) . The possibility of delivering various kinds of cytotoxic, antitumoral and/or photosensitising drugs via the receptormediated pathway of LDL has received much attention because various types of cancer cells have considerably higher LDL receptor activity than the corresponding normal cells (e.g. Norata et al., 1984; Vitols et al., 1985; Gal et al., 1981; Iwanik et al., 1984) . Such enhanced LDL activity is supposedly due to the high requirement for cholesterol in rapidly proliferating cells, LDL being the major extracellular vehicle for the transport of cholesterol to extrahepatic animal and human cells (Brown et al., 1981) .
Following administration of haematoporphyrin derivatives (HpD) to patients (D.I. Vernon, unpublished) or to experimental animals, the major tumour localising fraction preferentially binds to LDL and HDL (Kessel, 1986) . This fraction of HpD was not detected at all in high performance liquid chromatography (HPLC) analysis of the albumin fraction of the mouse plasma, neither 0.5 h nor 48 h after the administration of HpD. The binding of Hp and HpD to lipoproteins may influence their distribution in different tissues. Thus, administration to tumour-bearing mice of in vitro prepared complexes of Hp and LDL appears to deliver substantially more Hp to the mouse tumour (MS-2 fibrosarcoma) than does administration of Hp-complexes of very low density lipoproteins (VLDL), high density lipoproteins (HDL) or free Hp (Barel et al., 1986) .
In the present work we have studied the pattern of distribution among human plasma proteins of a range of porphyrin photosensitisers relevant to PDT. These It has been reported that some PDT sensitisers are cleared more rapidly from LDL than from HDL in mice, implying that there is no equilibrium redistribution (Barel et al., 1986; Kessel, 1986 Kessel et al. (1987) , and were tested chromatographically by that group. Their chromatographic analysis agreed with our own (Figure 4 ). Stock solutions of Hp, Pll, TPPS3 and TPPS4 were made up in 0.03 M NaOH + 0.15M NaCl, whereas dimethyl sulphoxid (DMSO) was stock solvent for Pp, Ppp, TPPS20 and TPPS2a.
All other chemicals used were of the highest purity commercially available.
Fresh human plasma sampled in EDTA tubes was used in all experiments and was obtained from the same healthy person who had fasted overnight. All (Chapman et al., 1981; Kelly & Krusky, 1986) , is slightly modified from that used by Redgrave et al. (1975) . The top fraction of the gradient was made up using 0.15 M NaCl, but at higher densities we employed CsCl instead of NaCl/KBr, as CsCl gives a lower molarity of salt at a given density. This fact may be important for the separation since it is well known that an increase in the salt concentration results in a decrease in porphyrin solubility. Furthermore, for the same reason we chose to apply the drug-containing plasma at the top of the gradient instead of at d= 1.15-1.312gml-1 as employed by other groups (Chapman et al., 1981; Nilsson et al., 1981; Kelly & Krusky, 1986; Redgrave et al., 1975) . Pure plasma gives a similar protein distribution pattern whether it was applied at the top or at the bottom of the gradient. Finally, we chose to use a density of 1.35 g ml-I at the bottom of the tube (Figure 1) , instead of 1.21, to prevent the heaviest proteins and/or protein-porphyrin complexes from precipitating at the bottom. Several gradients known from the literature (Chapman et al., 1981; Kelly & Krusky, 1986; Nilsson et al., 1981) were tested in a series of experiments using the SW-40 rotor and found to give similar relative separations as the gradient used by us. A separate paper, giving the explicit experimental data on which our choice of method is based, will be published later.
Concentration
The porphyrin binding patterns obtained here refer to 7 pgml-1 plasma in the case of Pll and 14 4gml-P plasma in the case of all other porphyrins. Reducing the plasma concentration by a factor of 5 while keeping the total porphyrin concentration constant (i.e. 35-70 pg porphyrin per ml plasma equivalent to 2.5-5mg per kg bodyweight) gave similar results as for 7-14pgml-1 for all substances tested in this respect, i.e. Hp, Pll, Pp and TPPS4. Analysis Gradients are often analysed from the bottom up. It was found that this method resulted in a contamination of the HDL fraction by other heavy proteins and an apparatus was therefore constructed which analysed and fractionated the gradient from the top downwards. By means of a peristaltic pump and an LKB 2098 Uvicord III monitor with appropriate optical filters the absorbences (1 cm) at 276 nm (proteins) and at 405 nm (porphyrins) were continuously monitored. Fractions were also collected and measured spectrophotometrically (Cary 118) since the tetraphenyl porphine sulphonates have their absorption maximum at 417 nm in our solvent. From one sample to another the position of the protein maxima in the gradient might change slightly (i.e. by ± one fraction). However, with three exceptions (see Results) the maxima of the porphyrin distribution coincided exactly with the maxima of the protein distribution in the same run.
HPLC
High performance liquid chromatography was carried out with an RP18 column and a methanol/water gradient buffered at pH7.4 as described previously (Sommer et al., 1984) .
Results
The initial gradient and that obtained after centrifugation are shown in Figure 1 Patch & Patch (1986) . Figure 2 .The maxima of the LDL, Lp(a), HDL and HSA peaks were found at fractions 4-5, 11-13, 17-19 and 28-29, respectively (Figures 2 and 3 ). In the cases of Hp, Pp, Ppp, PII, TPPS, TPPS1 and TPPS2a (Figures 1 and 2 ), the maxima of the dye distribution always coincide with the maxima of the protein peaks. However, in the case of TPPS3 the 417nm peak in the HDL-region was shifted by one fraction to the right compared to the 280 nm peak and in the case of TPPS20 the 417 nm peak in the HDL-region was shifted by three fractions to the right compared to the 280 nm peak. The latter shift is seen in the lower part of Figure 2 . Furthermore, the major peak of the TPPS4-adduct(s) is slightly shifted to the denser region of the heavy proteins by about one fraction, as seen in Figure 2 .
Integration over distributions, as shown in Table I . Thus, in the present work we have not attempted to measure thermodynamic affinities but only the relative distributions of the drugs between the plasma proteins. We emphasise that the concentration of each plasma protein in the samples has remained constant to within 5% throughout the work. There may be a slightly different distribution of aggregated and monomeric species among the different serum proteins. However, absorbance measurements as performed in the present work appear to give correct distributions since fluorescence measurement was found to give similar distributions (data not shown). (The fluorescence quantum yields of porphyrins are very sensitive to the state of aggregation.) The porphyrin amount bound to VLDL was small compared to that bound to LDL (less than 15%) and therefore these two fractions are taken together. Only Pp and TPPS2a showed a tendency to bind to Lp(a). Even in these two cases, the fraction of the porphyrins bound to Lp(a) is small compared to that bound to HDL (< 5%) and these two fractions are taken together in Table I .
When PII, Hp or Pp were incubated with plasma for different times (0, 4 and 16h) at 370C their distributions were almost identical to those shown in Figure 3 .
Discussion
The relative binding of the porphyrins to LDL increases generally, as expected, with increasing lipophilicity (Table I, Figure 3 ). Thus, Pp is more extensively bound to LDL than the structurally similar, but more polar Hp. Correspondingly, the relative binding of the porphyrins to the heavy proteins (mainly HSA) generally decreases with increasing lipophilicity, as best illustrated by the TPPS-series (Table I, Figure 3) . However, there are important exceptions to this general trend: Ppp and Hp bind similarly in the heavy protein region in spite of the fact that the latter porphyrin is significantly more polar than the former one. Similarly TPPS2a binds more extensively to LDL than does TPPS1, which is significantly less polar. This may be related to the asymmetric charge distribution on TPPS2a, which may cause a high affinity for a lipid/water interface. The asymmetry of TPPS2a has been previously invoked by Kessel et al. (1987) as an explanation for their observation that TPPS2a has a higher uptake in cells than TPPS1. In summary, the relative binding capacity LDL has for a drug is mainly related to the lipophilicity of the drug, although other factors, such as properties of different sidegroups and the asymmetry/ symmetry of the charge distribution play important roles for this affinity.
For most of the drugs we have tested, where these can be compared with results in the literature, there is generally broad agreement (Table I ). However, in the cases of Hp and TPPS2 we find relatively less in the heavy fraction and in the LDL fraction and more in the HLD fraction than did Reyftman et al. (1984) and Kessel et al. (1987) . The discrepancy is even greater in the case of TPPS3, for which we find much more in the HDL fraction and much less in the heavy protein fraction than did Kessel et al. (1987) . The porphyrins which we find mainly in the heavier part of HDL, i.e. in HDL3 (see Figure 1) , seem in Kessel's experiments to have been less well resolved from the albumin peak than in our case. This may be related to an effect of salt on the relative binding of TPPS3 as in his experiments the porphyrin-labelled plasma was applied at a high KBr concentration. Indeed, we have shown (unpublished results) that, in the case of Hp, high salt causes more Hp to bind in the heavy pattern region. The fact that TPPS3 and TPPS2o seem to be bound more substantially to the heavier subfraction of HDL than the other porphyrins tested should be noted. These compounds are more polar than TPPS2a and TPPS1, just as the heavier subfraction of HDL is more polar than its lighter fraction. It is also noteworthy that the TPPS4-peak at high densities seems to occur at a somewhat higher density than the protein peak in that region, implying that TPPS4 appears to be bound not only to albumin but also to one or more of the other heavy proteins.
HpD injected in mice is reported to be lost much faster from the LDL fraction than from the HDL fraction (Kessel, 1986) , as is Hp injected in mice and rabbits (Barel et al., 1986) . Consequently, these observations would seem to indicate that the binding and release of these drugs to the lipoproteins is slow and that LDL is degraded faster than HDL. The same group showed for systemic administration of Hp to cancer patients that, although Hp is lost with similar rates from LDL and HDL, it is lost at lower rates from VLDL (Jori et al., 1984) . However, from the present results the distributions of PII as well as those of Hp and Pp between the plasma proteins are similar for different incubation times ranging from 0 to 4 h (PIT) and 0 to 16 h (Hp and Pp) at 37°C (data not shown). Thus equilibrium seems to be rapidly reached. Similarly, recent results obtained by ultracentrifugation of sera from patients injected with PII indicate that there is no change in the distribution of the drug with time between injection and sampling (Brown et al., work in progress) , which is in agreement with our present results of rapid establishment of equilibrium. The possibility that there is a species difference in the relative stability of circulating porphyrin-lipoprotein complexes should be noted (but see below).
The assumption to be found in the literature that the tumour localising ability of porphyrins used in PDT may be related to their relative binding to LDL (Jori et al., 1984; Reyftman et al., 1984; Barel et al., 1986; Kessel, 1986 ) is not fully supported by the present work. Hp has a higher relative affinity for LDL than TPPS4 and Pp has an even higher affinity (Table I) Moan, 1986) . Moreover, TPPS4 has a very low affinity for LDL (see Table I ) and a relatively high affinity for heavy proteins, but is still one of the best tumour localisers studied so far, with respect both to absolute tumour uptake and to selectivity (Winkleman, 1985; Evensen, 1985; Peng et al., 1987) . According to Kessel et al. (1987) , albumin-bound drugs accumulate preferentially in stromal elements in tumour tissue while lipoprotein-bound drugs mediate intracellular localisation. As noted above, TPPS4 appears to be bound not only to albumin but also to other heavy proteins which may contribute to its distribution in vivo.
The tumour selectivity of a drug may be related as much to its retention in tumour tissue as to its initial deposition. For this initial deposition, LDL transport may play an important role. Thus, it has been shown that a lipophilic fluorophore carried by LDL is selectively deposited in endothelial cells in the vasculature (Netland et al., 1985) . Furthermore, strong PDT-effects on endothelial cells have been reported (Chaudhuri et al., 1987) . The difference in retention of different porphyrins in cells is demonstrated by our HPLC experiments, showing that washing of HpDloaded cells with a medium containing serum results in a selective removal of the monomeric components Hp, Pp and hydroxyethylvinyl deuteroporpohyrin (Moan & Sommer, 1983) .
Quite apart from the actual mechanisms of the drug uptake, there exists the possibility that the binding capacity for a drug (rather than its lipophilicity) is a good index for cellular uptake, as suggested by previous results for cellular uptake of TPPS analogues (Kessel et al., 1987 (Hambright et al., 1975; Winkelman, 1967) may also be important.
